FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137944974> ?p ?o ?g. }

• W3137944974 endingPage "2020" @default.
• W3137944974 startingPage "00624" @default.
• W3137944974 abstract "Observational studies report a reduction of COPD exacerbations in patients treated with β-blockers. In contrast, the Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (BLOCK COPD) randomised controlled trial which excluded COPD patients with cardiovascular conditions showed an increase in COPD exacerbations. It is unclear whether this discrepancy could be explained by underlying cardiovascular comorbidity. We examined whether the association between use of β-blockers and risk of COPD exacerbations differed between patients with and without a cardiovascular indication for β-blockers use. Within the Rotterdam Study, we followed COPD subjects until the first COPD exacerbation, or end of follow-up. Cardiovascular indication for β-blockers use was defined as a history of hypertension, coronary heart disease, atrial fibrillation and/or heart failure at baseline. The association between β-blockers use and COPD exacerbations was assessed using Cox proportional hazards models adjusted for age, sex, smoking, incident cardiovascular disease ( i.e. heart failure, hypertension, atrial fibrillation and/or coronary heart disease during follow-up), respiratory drugs and nitrates. In total, 1312 COPD patients with a mean age of 69.7±9.2 years were included. In patients with a cardiovascular indication (n=755, mean age of 70.4±8.8 years), current use of cardioselective β-blockers was significantly associated with a reduced risk of COPD exacerbations (HR 0.69, 95% CI 0.57–0.85). In contrast, in subjects without a cardiovascular indication (n=557, mean age of 68.8±9.7 years), current use of cardioselective β-blockers was not associated with an altered risk of COPD exacerbations (HR 0.94, 95% CI 0.55–1.62). Use of cardioselective β-blockers reduced the risk of exacerbations in COPD patients with concomitant cardiovascular disease. Therefore, the potential benefits of β-blockers might be confined to COPD patients with cardiovascular disease." @default.
• W3137944974 created "2021-03-29" @default.
• W3137944974 creator A5005167055 @default.
• W3137944974 creator A5007319489 @default.
• W3137944974 creator A5014850022 @default.
• W3137944974 creator A5054903767 @default.
• W3137944974 creator A5061121045 @default.
• W3137944974 creator A5076311551 @default.
• W3137944974 date "2021-03-18" @default.
• W3137944974 modified "2023-10-14" @default.
• W3137944974 title "Effect of β-blockers on the risk of COPD exacerbations according to indication of use: the Rotterdam Study" @default.
• W3137944974 cites W1821044976 @default.
• W3137944974 cites W1966494514 @default.
• W3137944974 cites W1994230402 @default.
• W3137944974 cites W1995442740 @default.
• W3137944974 cites W1999781152 @default.
• W3137944974 cites W2008043724 @default.
• W3137944974 cites W2009197337 @default.
• W3137944974 cites W2020720946 @default.
• W3137944974 cites W2040387366 @default.
• W3137944974 cites W2052247326 @default.
• W3137944974 cites W2053296636 @default.
• W3137944974 cites W2074016661 @default.
• W3137944974 cites W2075435092 @default.
• W3137944974 cites W2099246701 @default.
• W3137944974 cites W2100907993 @default.
• W3137944974 cites W2102018049 @default.
• W3137944974 cites W2107309698 @default.
• W3137944974 cites W2128669435 @default.
• W3137944974 cites W2129682084 @default.
• W3137944974 cites W2130479174 @default.
• W3137944974 cites W2132736079 @default.
• W3137944974 cites W2149943414 @default.
• W3137944974 cites W2164132830 @default.
• W3137944974 cites W2167115187 @default.
• W3137944974 cites W2294982910 @default.
• W3137944974 cites W2602534512 @default.
• W3137944974 cites W2742826145 @default.
• W3137944974 cites W2766497166 @default.
• W3137944974 cites W2888589263 @default.
• W3137944974 cites W2920797638 @default.
• W3137944974 cites W2979726429 @default.
• W3137944974 cites W2980413596 @default.
• W3137944974 cites W2988529816 @default.
• W3137944974 cites W3001051564 @default.
• W3137944974 cites W3023972366 @default.
• W3137944974 cites W4238907867 @default.
• W3137944974 doi "https://doi.org/10.1183/23120541.00624-2020" @default.
• W3137944974 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8236616" @default.
• W3137944974 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34195251" @default.
• W3137944974 hasPublicationYear "2021" @default.
• W3137944974 type Work @default.
• W3137944974 sameAs 3137944974 @default.
• W3137944974 citedByCount "1" @default.
• W3137944974 countsByYear W31379449742023 @default.
• W3137944974 crossrefType "journal-article" @default.
• W3137944974 hasAuthorship W3137944974A5005167055 @default.
• W3137944974 hasAuthorship W3137944974A5007319489 @default.
• W3137944974 hasAuthorship W3137944974A5014850022 @default.
• W3137944974 hasAuthorship W3137944974A5054903767 @default.
• W3137944974 hasAuthorship W3137944974A5061121045 @default.
• W3137944974 hasAuthorship W3137944974A5076311551 @default.
• W3137944974 hasBestOaLocation W31379449741 @default.
• W3137944974 hasConcept C126322002 @default.
• W3137944974 hasConcept C164705383 @default.
• W3137944974 hasConcept C204452808 @default.
• W3137944974 hasConcept C2776780178 @default.
• W3137944974 hasConcept C2777014857 @default.
• W3137944974 hasConcept C2778198053 @default.
• W3137944974 hasConcept C2779134260 @default.
• W3137944974 hasConcept C2779159551 @default.
• W3137944974 hasConcept C2779161974 @default.
• W3137944974 hasConcept C50382708 @default.
• W3137944974 hasConcept C50440223 @default.
• W3137944974 hasConcept C71924100 @default.
• W3137944974 hasConceptScore W3137944974C126322002 @default.
• W3137944974 hasConceptScore W3137944974C164705383 @default.
• W3137944974 hasConceptScore W3137944974C204452808 @default.
• W3137944974 hasConceptScore W3137944974C2776780178 @default.
• W3137944974 hasConceptScore W3137944974C2777014857 @default.
• W3137944974 hasConceptScore W3137944974C2778198053 @default.
• W3137944974 hasConceptScore W3137944974C2779134260 @default.
• W3137944974 hasConceptScore W3137944974C2779159551 @default.
• W3137944974 hasConceptScore W3137944974C2779161974 @default.
• W3137944974 hasConceptScore W3137944974C50382708 @default.
• W3137944974 hasConceptScore W3137944974C50440223 @default.
• W3137944974 hasConceptScore W3137944974C71924100 @default.
• W3137944974 hasIssue "2" @default.
• W3137944974 hasLocation W31379449741 @default.
• W3137944974 hasLocation W31379449742 @default.
• W3137944974 hasLocation W31379449743 @default.
• W3137944974 hasLocation W31379449744 @default.
• W3137944974 hasOpenAccess W3137944974 @default.
• W3137944974 hasPrimaryLocation W31379449741 @default.
• W3137944974 hasRelatedWork W2061473108 @default.
• W3137944974 hasRelatedWork W2067977631 @default.
• W3137944974 hasRelatedWork W2073453392 @default.
• W3137944974 hasRelatedWork W2550469198 @default.

• next